The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The known unknowns of HPV natural history
Open accessAbstract
The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly 100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by promoting the development of viral vaccines. Although the efficacy of these vaccines has already been demonstrated, a complete understanding of viral latency and natural immunity is lacking, and solving these mysteries could help guide policies of cervical cancer screening and vaccine use. Here, we examine the epidemiological and biological understanding of the natural history of HPV infection, with an eye toward using these studies to guide the implementation of cervical cancer prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
Mattapallil, J. J., Douek, D. C., Hill, B., Nishimura, Y., Martin, M., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,278
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,053
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P., Yates, M., Rollason, T. P., & Young, L. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04956-4 · Cited by 822
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., Herrero, R., & Franceschi, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08150-3 · Cited by 692
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., Shah, K. V., Meijer, C. J., & Bosch, F. X. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08151-5 · Cited by 684
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M., Désy, M., & Rohan, T. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/315086 · Cited by 657
Dillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Kjaer, S. K., Frederiksen, K., Munk, C., & Iftner, T. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq356 · Cited by 579
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Strickler, H. D., Burk, R. D., Fazzari, M., Anastos, K., Minkoff, H., Massad, L. S., Hall, C., Bacon, M., Levine, A. M., Watts, D. H., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji073 · Cited by 519
Muñoz, N., Manalastas, R., Pitisuttithum, P., Tresukosol, D., Monsonego, J., Ault, K., Clavel, C., Luna, J., Myers, E., Hood, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60691-7 · Cited by 478
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study
Plummer, M., Herrero, R., Franceschi, S., Meijer, C. J. L. M., Snijders, P., Bosch, F. X., de Sanjosé, S., & Muñoz, N. (2003) · Cancer Causes & Control · doi:10.1023/b:caco.0000003811.98261.3e · Cited by 423
Brown, D. R., Shew, M. L., Qadadri, B., Neptune, N., Vargas, M., Tu, W., Juliar, B. E., Breen, T. E., & Fortenberry, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/426867 · Cited by 418
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
Muñoz, N., Méndez, F., Posso, H., Molano, M., van den Brule, A. J. C., Ronderos, M., Meijer, C., Muñoz, Á., & Instituto Nacional de Cancerología HPV study group (2004) · The Journal of Infectious Diseases · doi:10.1086/425907 · Cited by 395
Rodriguez, A. C., Schiffman, M., Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Solomon, D., Guillen, D., Alfaro, M., Morales, J., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq001 · Cited by 383
Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., García, P., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0031 · Cited by 328
Tronstein, E. (2011) · JAMA · doi:10.1001/jama.2011.420 · Cited by 298
Purwar, R., Campbell, J., Murphy, G., Richards, W. G., Clark, R. A., & Kupper, T. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016245 · Cited by 288
Naucler, P., Ryd, W., Tornberg, S., Strand, A., Wadell, G., Elfgren, K., Radberg, T., Strander, B., Forslund, O., Hansson, B.-G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn444 · Cited by 287
Leinonen, M., Nieminen, P., Kotaniemi-Talonen, L., Malila, N., Tarkkanen, J., Laurila, P., & Anttila, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp367 · Cited by 259
Schick, V., Herbenick, D., Reece, M., Sanders, S. A., Dodge, B., Middlestadt, S. E., & Fortenberry, J. D. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02013.x · Cited by 254
Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner
Winer, R. L., Feng, Q., Hughes, J. P., O’Reilly, S., Kiviat, N. B., & Koutsky, L. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/524875 · Cited by 230
Goldie, S. J., Grima, D., Kohli, M., Wright, T. C., Weinstein, M., & Franco, E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11334 · Cited by 209
The natural history of human papillomavirus infections of the mucosal epithelia
CHOW, L. T., BROKER, T. R., & STEINBERG, B. M. (2010) · APMIS · doi:10.1111/j.1600-0463.2010.02625.x · Cited by 206
Human Papillomavirus Vaccines: Current Status and Future Prospects
Garland, S. M., & Smith, J. S. (2010) · Drugs · doi:10.2165/10898580-000000000-00000 · Cited by 190
Viscidi, R. P., Schiffman, M., Hildesheim, A., Herrero, R., Castle, P. E., Bratti, M. C., Rodriguez, A. C., Sherman, M. E., Wang, S., Clayman, B., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0166 · Cited by 189
Maglennon, G. A., McIntosh, P., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.019 · Cited by 175
Safaeian, M., Porras, C., Schiffman, M., Rodriguez, A. C., Wacholder, S., Gonzalez, P., Quint, W., van Doorn, L.-J., Sherman, M. E., Xhenseval, V., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq384 · Cited by 173
Ho, G. Y. F., Studentsov, Y., Hall, C. B., Bierman, R., Beardsley, L., Lempa, M., & Burk, R. D. (2002) · The Journal of Infectious Diseases · doi:10.1086/342972 · Cited by 166
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
Garnett, G. P., Kim, J. J., French, K., & Goldie, S. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.116 · Cited by 162
Trottier, H., Ferreira, S., Thomann, P., Costa, M. C., Sobrinho, J. S., Prado, J. C. M., Rohan, T. E., Villa, L. L., & Franco, E. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0621 · Cited by 158
McIntyre‐Seltman, K., Castle, P. E., Guido, R. S., SCHIFFMAN, M. H., Wheeler, C. M., & for The ALTS Group (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0918 · Cited by 149
Modeling Cervical Cancer Prevention in Developed Countries
Kim, J. J., Brisson, M., Edmunds, W. J., & Goldie, S. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.009 · Cited by 143
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Collins, S. I., Rollason, T. P., Young, L. S., & Woodman, C. B. J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.015 · Cited by 136
Romanowski, B. (2011) · Human Vaccines · doi:10.4161/hv.7.2.13690 · Cited by 127
Schiffer, J. T., Abu-Raddad, L. J., Mark, K. E., Zhu, J., Selke, S., Koelle, D. M., Wald, A., & Corey, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006614107 · Cited by 126
Kim, J. J., Ortendahl, J., & Goldie, S. J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00007 · Cited by 119
Castellsagué, X., Schneider, A., Kaufmann, A. M., & Bosch, F. X. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.021 · Cited by 112
Insinga, R. P., Pérez, G., Wheeler, C. M., Koutsky, L. A., Garland, S. M., Leodolter, S., Joura, E. A., Ferris, D. G., Steben, M., Brown, D. R., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1235 · Cited by 100
González, P., Hildesheim, A., Rodríguez, A. C., SCHIFFMAN, M. H., Porras, C., Wacholder, S., García‐Piñeres, A., Pinto, L. A., Burk, R. D., & Herrero, R. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0645 · Cited by 100
Van de Velde, N., Brisson, M., & Boily, M.-C. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.056 · Cited by 87
Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
Schwarz, T. F. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0079-5 · Cited by 83
Weaver, K. (2002) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118902101196405 · Cited by 82
Latent human papillomavirus infection is comparable in the larynx and trachea
Abramson, A. L., Nouri, M., Mullooly, V. M., Fisch, G. S., & Steinberg, B. M. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20013 · Cited by 81
Lu, B., Viscidi, R. P., Lee, J., Wu, Y., Villa, L. L., Lazcano-Ponce, E. C., da Silva, R. J. C., Baggio, M. L., Quiterio, M., Salmerón, J., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1160 · Cited by 81
Selvakumar, R., Schmitt, A., Iftner, T., Ahmed, R., & Wettstein, F. O. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5540-5548.1997 · Cited by 71
High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus–Infected Women
Theiler, R. N., Farr, S. L., Karon, J. M., Paramsothy, P., Viscidi, R. P., Duerr, A. C., Cu‐Uvin, S., Sobel, J. D., Shah, K. V., Klein, R. S., et al. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e00927 · Cited by 66
Haupt, R. M., Wheeler, C. M., Brown, D. R., Garland, S. M., Ferris, D. G., Paavonen, J. A., Lehtinen, M., Steben, M., Joura, E. A., Giacoletti, K. E. D., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25940 · Cited by 63
Wang, C., Wright, T. C., Denny, L., & Kuhn, L. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq083 · Cited by 60
Induction of E6/E7 Expression in Cottontail Rabbit Papillomavirus Latency Following UV Activation
Zhang, P., Nouri, M., Brandsma, J. L., Iftner, T., & Steinberg, B. M. (1999) · Virology · doi:10.1006/viro.1999.9950 · Cited by 57
Amella, C. A., Löfgren, L., Ronn, A. M., Nouri, M., Shikowitz, M. J., & Steinberg, B. M. (1994) · PubMed · Cited by 56
Prevalence and Incidence of HPV Genital Infection in Women
Velicer, C. M., Zhu, X., Vuocolo, S. C., Liaw, K., & Saah, A. J. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181ad25ff · Cited by 55
A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US
Dunne, E. F., Datta, S., & Markowitz, L. E. (2008) · Cancer · doi:10.1002/cncr.23763 · Cited by 54
Increases in Human Papillomavirus Detection During Early HIV Infection Among Women in Zimbabwe
Nowak, R. G., Gravitt, P. E., MORRISON, C. S., Gange, S. J., Kwok, C., Oliver, A., Howard, R., Pol, B. J. V. D., Salata, R. A., PADIAN, N. S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq172 · Cited by 53
Self-citationPignatari, S. S. N., Smith, E., Shive, C. J., Gray, S. D., & Turek, L. P. (1992) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949210100506 · Cited by 49
Risk estimation for the next generation of prevention programmes for cervical cancer
Katki, H. A., Wacholder, S., Solomon, D., Castle, P. E., & SCHIFFMAN, M. H. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70253-0 · Cited by 43
Malik, Z. A., Hailpern, S. M., & Burk, R. D. (2009) · Viral Immunology · doi:10.1089/vim.2009.0055 · Cited by 41
Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States
Grant, L. A., Dunne, E. F., Chesson, H. W., & Markowitz, L. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.032 · Cited by 31
Cited by
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Prevalence of Oral HPV Infection in the United States, 2009-2010
Gillison, M. L., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., Graubard, B. I., & Chaturvedi, A. K. (2012) · JAMA · doi:10.1001/jama.2012.101 · Cited by 1,064
Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.552028 · Cited by 646
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Wang, R., Pan, W., Jin, L., Huang, W., Li, Y., Wu, D., Gao, C., Ma, D., & Liao, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.039 · Cited by 493
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
Berman, T. A., & Schiller, J. T. (2017) · Cancer · doi:10.1002/cncr.30588 · Cited by 395
Metadata
- Authors
- Gravitt, P. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-12-01
- Volume
- 121
- Issue
- 12
- Pages
- 4593-4599
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1964162820
- Cited by
- 378
- References
- 75
- FWCI
- 24.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.